In the past week, ROIV stock has gone up by 1.54%, with a monthly gain of 6.83% and a quarterly surge of 19.40%. The volatility ratio for the week is 4.05%, and the volatility levels for the last 30 days are 4.91% for Roivant Sciences Ltd. The simple moving average for the last 20 days is 3.36% for ROIV’s stock, with a simple moving average of 40.60% for the last 200 days.
Is It Worth Investing in Roivant Sciences Ltd. (NASDAQ: ROIV) Right Now?
There are mixed opinions on the stock, with 8 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
The average price estimated by analysts for ROIV is $14.00, which is $4.77 above than the current price. The public float for ROIV is 440.82M, and at present, short sellers hold a 3.26% of that float. The average trading volume of ROIV on May 26, 2023 was 3.03M shares.
ROIV) stock’s latest price update
The stock price of Roivant Sciences Ltd. (NASDAQ: ROIV) has jumped by 0.11 compared to previous close of 9.22. Despite this, the company has seen a gain of 1.54% in its stock price over the last five trading days. Barron’s reported on 02/28/22 that Moderna Faces Patent Lawsuit on Covid-19 Vaccine
ROIV Trading at 11.22% from the 50-Day Moving Average
After a stumble in the market that brought ROIV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -7.70% of loss for the given period.
Volatility was left at 4.91%, however, over the last 30 days, the volatility rate increased by 4.05%, as shares surge +9.49% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.45% upper at present.
During the last 5 trading sessions, ROIV rose by +1.54%, which changed the moving average for the period of 200-days by +129.03% in comparison to the 20-day moving average, which settled at $8.97. In addition, Roivant Sciences Ltd. saw 15.52% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ROIV starting from Venker Eric, who sale 415 shares at the price of $9.85 back on May 23. After this action, Venker Eric now owns 675,768 shares of Roivant Sciences Ltd., valued at $4,088 using the latest closing price.
Venker Eric, the President & COO of Roivant Sciences Ltd., sale 238,724 shares at $9.23 during a trade that took place back on May 09, which means that Venker Eric is holding 675,768 shares at $2,203,423 based on the most recent closing price.
Stock Fundamentals for ROIV
Equity return is now at value -96.60, with -51.90 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 3.58.
Conclusion
In summary, Roivant Sciences Ltd. (ROIV) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
